Clinical Trial Update: 18F-FLT-PET Imaging of the Brain in Patients With Metastatic Breast Cancer to the Brain Treated With Whole Brain Radiation Therapy With or Without Sorafenib: Comparison With MR Imaging of the Brain [NA]

View source ↗

Summary

A completed clinical trial evaluating 18F-FLT-PET imaging of the brain in patients with metastatic breast cancer to the brain treated with whole brain radiation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer to the Brain

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Metastatic Breast Cancer to the Brain | NA | Status: COMPLETED | Results posted: 2022-09-09